12 Cutting-Edge Medical Technology Companies from Zhongke Showcase Their Strength at the 2023 Asia Biotech Exhibition

The "2023 Asia Biotech Conference (BIO Asia-Taiwan 2023)" is taking place from today (August 27) to August 30 at the Taipei Nangang Exhibition Center. The National Science and Technology Council (NSTC) is leading 12 standout companies from the Zhongke Science Park to participate, aiming to capture new opportunities in the biotech industry and enhance international promotion.

Among the participants, Chang Sheng International Biotechnology and Zheng Han Biotechnology have been awarded the "2023 Taiwan BIO Award" Gold Award and the Industry Innovation Award, respectively. These accolades highlight the robust biotech R&D capabilities of Zhongke and its commitment to developing a new hub for innovative smart healthcare industries.

NSTC Vice Chair Chen Yi-Chuang and Zhongke Administration Deputy Director Shi Wen-Fang visited the science park's themed pavilion to cheer on the exhibiting companies. This year, the Zhongke pavilion focuses on "Precision Health, Digital Medicine, and Cross-Domain Innovation." The companies in the park are showcasing their achievements across fields such as precision medicine, new biotech drugs, innovative medical technologies, medical devices, and smart automation through a collaborative exhibition.

To assist companies in creating business opportunities and increasing industry collaboration, Zhongke is actively participating in technical presentations at the NSTC forum area. The goal is to leverage the BIO network to build a brand image for the science park cluster, attract cross-domain connections, and new investment.

The Zhongke pavilion features 12 standout companies:

- **Ming An Technology** focuses on environmentally friendly product technologies, developing compostable materials and whole plant export cooperation.

- **Taiwan Lide** specializes in the development of new drugs from the future of Antrodia cinnamomea, elevating industrial applications to new heights.

- **Zhonghua Health** develops Kefu peptide materials for applications in blood pressure, bone quality, and joints.

- **Hejin Technology** offers AI smart care systems for site safety.

- **Demong Instruments** applies endoscopes in medical, industrial, aerospace, and semiconductor fields, representing a Taiwanese brand.

- **Idat Medical** provides cutting-edge medical equipment products aimed at enhancing health and quality of life.

- **Yuzhan New Drug** develops long-acting sustained-release injectable drugs to help patients return to daily life.

- **Yucheng Technology** works on far-infrared flexible heating elements and modules for consumer markets.

- **Taiwan Meizhao** manufactures high-tech nano PTFE (polytetrafluoroethylene) membrane products, promoting a new generation of hydrogen economy.

- **Riyang Technology** specializes in the production of reduction motors, applicable in automation, medical, and energy sectors.

- **Jingde Biomedical** develops advanced medical materials with hyaluronic acid for wound healing and hemostasis.

- **Elit** integrates biotechnology with cosmetics, health products, and medical aesthetics.

The participation of these 12 standout companies at the "2023 Asia Biotech Exhibition" vividly demonstrates their advanced biotech R&D achievements and contributes to building an innovative medical ecosystem. Moving forward, Zhongke will continue to combine the top biotech and medical technology R&D and manufacturing capabilities in central Taiwan to construct a precision health industry chain and assist companies in expanding into international markets, showcasing Taiwan's biotech strength to the world.

This article is reprinted from the Economic Daily News by reporter Song Jian-Sheng /in Taichung